Limbix is developing a pipeline of digital therapeutics for adolescent mental health disorders. We are passionate about creating evidence-based digital programs to increase young people's access to clinically effective mental health treatment. Our first product, SparkRx, is a digital therapeutic that provides an evidence-based adjunct treatment intervention for adolescents aged 13-22 with symptoms of depression. SparkRx provides the core components of behavioral activation therapy to young people with symptoms of depression. The 5-week program provides clinicians with an immediate and safe adjunct treatment option they can offer their patients. SparkRx is delivered via smartphone app, and includes features such as psychoeducation, activity scheduling, mood tracking, and mindfulness.
AAP Nat Con